At BPI Labs, patient safety is our top priority. We are dedicated to ensuring that every sterile injectable we manufacture meets the highest standards of quality, efficacy, and safety. Our Drug Safety team actively monitors and assesses potential safety concerns, working diligently to identify, review, and report any adverse events or safety findings related to our products.

By maintaining strict compliance with regulatory guidelines, we ensure that all safety data is promptly communicated to the appropriate health authorities. Our proactive approach to pharmacovigilance allows us to continually improve our products and provide healthcare professionals with the safe, reliable medications they need to support patient care.

If you have a safety concern or adverse event related to one of our products, please contact us immediately.